Arkolith/Insider Trading/REVB/Form 4

Zygmont Chester Stanley III

Chief Financial OfficerREVELATION BIOSCIENCES, INC. (REVB) · full profile →Form 4 · filed Oct 31, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 29, 2025Grant(A)391K$1.28$500K396K

Transaction Codes

A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-25-260417) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML